---
figid: PMC9231801__ppat.1010547.g002
figtitle: 'Three stages of immunological pathway leading to mortality in COVID-19:
  Stage I (Initiation), with early induction of predominant chemokines upon SARS-CoV-2
  infection and viral sepsis'
organisms:
- NA
pmcid: PMC9231801
filename: ppat.1010547.g002.jpg
figlink: /pmc/articles/PMC9231801/figure/ppat.1010547.g002/
number: F2
caption: 'Treatment at this stage with CVC (highlighted in blue text and arrows) is
  postulated to maintain normalized myeloid compartmentalization at early stage of
  infection, or block aberrant myeloid infiltration upon CCL2, 3, and 5 signaling
  following SARS-CoV-2 infection and consequent cytokine amplification (Stage II),
  and subsequent tissue damage and eventual death (Stage III—consummation). Lu L,
  et al. Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a
  Raging Storm? Front Cell Dev Biol. 2020;8:677. https://doi.org/10.3389/fcell.2020.00677.
  CCL, chemokine-chemokine ligand; CCR, chemokine-chemokine receptor; COVID-19, Coronavirus
  Disease 2019; CVC, cenicriviroc; IL, interleukin; IP, interferon gamma-induced protein;
  SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2; TNF, tumor necrosis
  factor.'
papertitle: Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc
  for the treatment of COVID-19.
reftext: Daniel Clark Files, et al. PLoS Pathog. 2022 Jun;18(6):e1010547.
year: '2022'
doi: 10.1371/journal.ppat.1010547
journal_title: PLoS Pathogens
journal_nlm_ta: PLoS Pathog
publisher_name: Public Library of Science
keywords: ''
automl_pathway: 0.9067446
figid_alias: PMC9231801__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC9231801__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9231801__ppat.1010547.g002.html
  '@type': Dataset
  description: 'Treatment at this stage with CVC (highlighted in blue text and arrows)
    is postulated to maintain normalized myeloid compartmentalization at early stage
    of infection, or block aberrant myeloid infiltration upon CCL2, 3, and 5 signaling
    following SARS-CoV-2 infection and consequent cytokine amplification (Stage II),
    and subsequent tissue damage and eventual death (Stage III—consummation). Lu L,
    et al. Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in
    a Raging Storm? Front Cell Dev Biol. 2020;8:677. https://doi.org/10.3389/fcell.2020.00677.
    CCL, chemokine-chemokine ligand; CCR, chemokine-chemokine receptor; COVID-19,
    Coronavirus Disease 2019; CVC, cenicriviroc; IL, interleukin; IP, interferon gamma-induced
    protein; SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2; TNF, tumor
    necrosis factor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CCR2
  - MAP6
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - CCL2
  - CCL3
  - CCL5
  - IL1A
  - IL2
  - IL6
  - IL10
  - TNF
  - CCR5
  - LINC00689
  - ACKR2
  - CCR1
  - CCR10
  - CCR3
  - CCR4
  - CCR6
  - CCR7
  - CCR8
  - CCR9
  - ACKR4
  - CCRL2
  - CX3CR1
  - CXCR1
  - CXCR2
  - CXCR3
  - CXCR4
  - CXCR5
  - CXCR6
  - ACKR3
  - XCR1
  - IL6R
---
